Besides leukemia, miR-582 has been shown to inhibit the development of solid tumors, including non-small cell lung cancer [35], bladder cancer [36], and human colorectal carcinoma [37], by targeting different gene, such as Hippo-YAP, TTK, and Rab27a. Here, TTK is linked to urinary bladder cancer.